Table 2 Selection of hormone therapy and chemotherapy
From: The mode of progressive disease affects the prognosis of patients with metastatic breast cancer
No. | |
|---|---|
Chemotherapy | |
Oral 5FU | 62 |
Taxane | 47 |
Anthracycline | 17 |
Vinorelbine | 17 |
Eribulin | 12 |
Paclitaxel + Bevacizumab | 11 |
Targeted drug alone | 9 |
Others | 26 |
Hormone therapy | |
Non-steroidal AI | 66 |
Steroidal AI | 36 |
SERM | 52 |
SERD | 9 |
MPA | 6 |